Increased intravenous morphine self-administration following Roux-en-Y gastric bypass in dietary obese rats

Jessica M. Biegler, Christopher Freet, Nelli Horvath, Ann Rogers, Andras Hajnal

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Roux-en-Y gastric bypass (RYGB) surgery is a commonly performed and very effective method to achieve significant, long-term weight loss. Opioid analgesics are primarily used to manage postoperative pain as fewer alternative medication options are available for bariatric surgery patients than for the general population. Recent clinical studies support a greater risk for substance use following bariatric surgery, including an increased use of opioid medications. The present study is the first to study morphine self-administration in a rat model of RYGB. High fat diet-induced obese (HFD-DIO) rats underwent RYGB (n = 14) or sham-surgery with ad libitum HFD (SHAM, n = 14) or a restricted amount that resulted in weight matched to the RYGB cohort (SHAM-WM, n = 8). An additional normal-diet (ND, n = 7), intact (no surgery) group of rats was included. Two months after the surgeries, rats were fitted with jugular catheters and trained on a fixed ratio-2 lick task to obtain morphine intravenously. Both morphine-seeking (number of licks on an empty spout to obtain morphine infusion) and consumption (number of infusion) were significantly greater in RYGB than any control group beginning on day 3 and reached a two-fold increase over a period of two weeks. These findings demonstrate that RYGB increases motivation for taking morphine and that this effect is independent of weight loss. Further research is warranted to reveal the underlying mechanisms and to determine whether increased morphine use represents a risk for opioid addiction following RYGB. Identifying risk factors preoperatively could help with personalized postoperative care to prevent opioid abuse and addiction.

Original languageEnglish (US)
Pages (from-to)47-52
Number of pages6
JournalBrain Research Bulletin
Volume123
DOIs
StatePublished - May 1 2016

Fingerprint

Self Administration
Gastric Bypass
Morphine
Opioid Analgesics
Bariatric Surgery
Weight Loss
Postoperative Care
High Fat Diet
Postoperative Pain
Neck
Catheters
Diet
Weights and Measures
Control Groups
Research
Population

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{1b1c7eb0915e4feabb5325e3bb907166,
title = "Increased intravenous morphine self-administration following Roux-en-Y gastric bypass in dietary obese rats",
abstract = "Roux-en-Y gastric bypass (RYGB) surgery is a commonly performed and very effective method to achieve significant, long-term weight loss. Opioid analgesics are primarily used to manage postoperative pain as fewer alternative medication options are available for bariatric surgery patients than for the general population. Recent clinical studies support a greater risk for substance use following bariatric surgery, including an increased use of opioid medications. The present study is the first to study morphine self-administration in a rat model of RYGB. High fat diet-induced obese (HFD-DIO) rats underwent RYGB (n = 14) or sham-surgery with ad libitum HFD (SHAM, n = 14) or a restricted amount that resulted in weight matched to the RYGB cohort (SHAM-WM, n = 8). An additional normal-diet (ND, n = 7), intact (no surgery) group of rats was included. Two months after the surgeries, rats were fitted with jugular catheters and trained on a fixed ratio-2 lick task to obtain morphine intravenously. Both morphine-seeking (number of licks on an empty spout to obtain morphine infusion) and consumption (number of infusion) were significantly greater in RYGB than any control group beginning on day 3 and reached a two-fold increase over a period of two weeks. These findings demonstrate that RYGB increases motivation for taking morphine and that this effect is independent of weight loss. Further research is warranted to reveal the underlying mechanisms and to determine whether increased morphine use represents a risk for opioid addiction following RYGB. Identifying risk factors preoperatively could help with personalized postoperative care to prevent opioid abuse and addiction.",
author = "Biegler, {Jessica M.} and Christopher Freet and Nelli Horvath and Ann Rogers and Andras Hajnal",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.brainresbull.2015.08.003",
language = "English (US)",
volume = "123",
pages = "47--52",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",

}

Increased intravenous morphine self-administration following Roux-en-Y gastric bypass in dietary obese rats. / Biegler, Jessica M.; Freet, Christopher; Horvath, Nelli; Rogers, Ann; Hajnal, Andras.

In: Brain Research Bulletin, Vol. 123, 01.05.2016, p. 47-52.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Increased intravenous morphine self-administration following Roux-en-Y gastric bypass in dietary obese rats

AU - Biegler, Jessica M.

AU - Freet, Christopher

AU - Horvath, Nelli

AU - Rogers, Ann

AU - Hajnal, Andras

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Roux-en-Y gastric bypass (RYGB) surgery is a commonly performed and very effective method to achieve significant, long-term weight loss. Opioid analgesics are primarily used to manage postoperative pain as fewer alternative medication options are available for bariatric surgery patients than for the general population. Recent clinical studies support a greater risk for substance use following bariatric surgery, including an increased use of opioid medications. The present study is the first to study morphine self-administration in a rat model of RYGB. High fat diet-induced obese (HFD-DIO) rats underwent RYGB (n = 14) or sham-surgery with ad libitum HFD (SHAM, n = 14) or a restricted amount that resulted in weight matched to the RYGB cohort (SHAM-WM, n = 8). An additional normal-diet (ND, n = 7), intact (no surgery) group of rats was included. Two months after the surgeries, rats were fitted with jugular catheters and trained on a fixed ratio-2 lick task to obtain morphine intravenously. Both morphine-seeking (number of licks on an empty spout to obtain morphine infusion) and consumption (number of infusion) were significantly greater in RYGB than any control group beginning on day 3 and reached a two-fold increase over a period of two weeks. These findings demonstrate that RYGB increases motivation for taking morphine and that this effect is independent of weight loss. Further research is warranted to reveal the underlying mechanisms and to determine whether increased morphine use represents a risk for opioid addiction following RYGB. Identifying risk factors preoperatively could help with personalized postoperative care to prevent opioid abuse and addiction.

AB - Roux-en-Y gastric bypass (RYGB) surgery is a commonly performed and very effective method to achieve significant, long-term weight loss. Opioid analgesics are primarily used to manage postoperative pain as fewer alternative medication options are available for bariatric surgery patients than for the general population. Recent clinical studies support a greater risk for substance use following bariatric surgery, including an increased use of opioid medications. The present study is the first to study morphine self-administration in a rat model of RYGB. High fat diet-induced obese (HFD-DIO) rats underwent RYGB (n = 14) or sham-surgery with ad libitum HFD (SHAM, n = 14) or a restricted amount that resulted in weight matched to the RYGB cohort (SHAM-WM, n = 8). An additional normal-diet (ND, n = 7), intact (no surgery) group of rats was included. Two months after the surgeries, rats were fitted with jugular catheters and trained on a fixed ratio-2 lick task to obtain morphine intravenously. Both morphine-seeking (number of licks on an empty spout to obtain morphine infusion) and consumption (number of infusion) were significantly greater in RYGB than any control group beginning on day 3 and reached a two-fold increase over a period of two weeks. These findings demonstrate that RYGB increases motivation for taking morphine and that this effect is independent of weight loss. Further research is warranted to reveal the underlying mechanisms and to determine whether increased morphine use represents a risk for opioid addiction following RYGB. Identifying risk factors preoperatively could help with personalized postoperative care to prevent opioid abuse and addiction.

UR - http://www.scopus.com/inward/record.url?scp=84940099632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940099632&partnerID=8YFLogxK

U2 - 10.1016/j.brainresbull.2015.08.003

DO - 10.1016/j.brainresbull.2015.08.003

M3 - Article

C2 - 26304761

AN - SCOPUS:84940099632

VL - 123

SP - 47

EP - 52

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

ER -